Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,102 | Dovepress* | 7,102+ | 955 | 8,057 | |
| PubMed Central* | 1,000 | 329 | 1,329 | ||
| Totals | 8,102 | 1,284 | 9,386 | ||
| *Since 14 November 2017 | |||||
View citations on PubMed Central and Google Scholar